Admaris Pharmaceuticals Private Limited
Manufactures and sells medicines, operates hospitals for treating illnesses.
2014 | Lucknow, Uttar Pradesh (India) | Active
Admaris Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 33.75%
- Profit Growth 69.58%
- Ebitda -4.32%
- Net Worth 2.75%
- Total Assets 14.38%
About Admaris Pharmaceuticals
Admaris Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 November 2014 and has a history of Ten years and three months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Gulsifat Ara, Aradhana Pandey, Bashisth Srivastava, and Four other members serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85191UP2014PTC066809
- Company No.
066809
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Pharma
Who are the key members and board of directors at Admaris Pharmaceuticals?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gulsifat Ara  | Director | 28-Nov-2018 | Current |
| Aradhana Pandey | Director | 22-Feb-2018 | Current |
| Bashisth Srivastava | Director | 08-Jan-2018 | Current |
| Mohammad Shadab | Director | 03-Nov-2014 | Current |
| Irshad Ahmad | Director | 03-Nov-2014 | Current |
| Mohd Altaaf | Director | 03-Nov-2014 | Current |
Financial Performance of Admaris Pharmaceuticals.
Admaris Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.75% increase. The company also saw a substantial improvement in profitability, with a 69.58% increase in profit. The company's net worth moved up by a moderate rise of 2.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Admaris Pharmaceuticals?
Unlock access to Admaris Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Admaris Consumer Products Private Limited
Mohammad Shadab, Irshad Ahmad and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Admaris Pharmaceuticals?
Unlock and access historical data on people associated with Admaris Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Admaris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Admaris Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.